Timothy L Wiemken
Overview
Explore the profile of Timothy L Wiemken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1091
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wiemken T, McGrath L, Andersen K, Khan F, Malhotra D, Alfred T, et al.
Clin Infect Dis
. 2022 Aug;
76(3):e42-e50.
PMID: 35984816
Background: Little is known about the relationship between coronavirus disease 2019 (COVID-19) severity and subsequent risk of experiencing a cardiovascular event (CVE) after COVID-19 recovery. We evaluated this relationship in...
12.
Wang G, Stapleton J, Baker A, Rouphael N, Creech C, El Sahly H, et al.
Open Forum Infect Dis
. 2022 Aug;
9(8):ofac375.
PMID: 35959208
Coinfections are more common in patients with cystic fibrosis and bronchiectasis. Infiltrates on imaging studies are seen more commonly in patients with coinfections, but coinfections did not affect treatment outcomes...
13.
McLaughlin J, Wiemken T, Khan F, Jodar L
Open Forum Infect Dis
. 2022 Jul;
9(7):ofac299.
PMID: 35873296
The population-level impact of vaccination on Omicron-related disease is not well described. We fit negative binomial models to estimate the relationship between US county-level vaccine coverage and rates of coronavirus...
14.
Wiemken T, Salas J, Hoft D, Jacobs C, Morley J, Scherrer J
Vaccine
. 2022 Jun;
40(26):3529.
PMID: 35644208
No abstract available.
15.
Di Fusco M, Marczell K, Deger K, Moran M, Wiemken T, Cane A, et al.
J Med Econ
. 2022 May;
25(1):605-617.
PMID: 35574613
Background: As the body of evidence on COVID-19 and post-vaccination outcomes continues to expand, this analysis sought to evaluate the public health impact of the Pfizer-BioNTech COVID-19 Vaccine, BNT162b2, during...
16.
Abate G, Kapoor A, Charbek E, Beck B, Wang Q, Wang G, et al.
J Natl Med Assoc
. 2022 Jan;
114(1):56-68.
PMID: 35012764
Background And Aims: Recent reports indicate that African Americans have higher mortality rates from SARS-CoV-2 coronavirus disease 19 (COVID-19) compared to Caucasians, with more marked differences in the Midwest region...
17.
Rutschman A, Sarnoff J, Wiemken T
Methods Mol Biol
. 2021 Dec;
2412:519-525.
PMID: 34918266
We analyzed the intellectual property landscape surrounding currently available vaccines, with a focus on patents.
18.
Wiemken T, Salas J, Morley J, Hoft D, Jacobs C, Scherrer J
J Am Geriatr Soc
. 2021 Dec;
70(4):1157-1168.
PMID: 34897645
Background: Multiple types of vaccinations are associated with lower risk for dementia, but it is not known if receiving more than one vaccination type is associated with a greater decrease...
19.
Scherrer J, Salas J, Wiemken T, Hoft D, Jacobs C, Morley J
PLoS One
. 2021 Nov;
16(11):e0257405.
PMID: 34788293
Background: Herpes zoster (HZ) infection increases dementia risk, but it is not known if herpes zoster vaccination is associated with lower risk for dementia. We determined if HZ vaccination, compared...
20.
Wiemken T, Niemotka S, Clarke J, Prener C, Rutschman A
Am J Infect Control
. 2021 Oct;
50(1):4-7.
PMID: 34718068
Background: COVID-19 continues to disturb nearly all aspects of life, leaving us striving to reach herd immunity. Currently, only weekly standardized incidence rate data per age group are publicly available,...